Journal
HUMAN MOLECULAR GENETICS
Volume 19, Issue 15, Pages 3043-3052Publisher
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddq209
Keywords
-
Funding
- Clinical Research Fellowship [G0701386]
- Parkinson's Disease Society (UK)
- Medical Research Council Translational Muscle Centre
- UK NIHR Biomedical Research Centre in Ageing and Age related disease
- NIH/NIGMS [R01GM073744]
- Helse Vest (RHF)
- Norwegian Research Council
- Academy of Medical Sciences
- Deutsche Forschungsgemeinschaft [HO 2505/2-1]
- Wellcome Trust
- Medical Research Council [G0701386, G0700718] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish
- MRC [G0701386, G0700718] Funding Source: UKRI
Ask authors/readers for more resources
Pathogenic OPA1 mutations cause autosomal dominant optic atrophy (DOA),a condition characterized by the preferential loss of retinal ganglion cells and progressive optic nerve degeneration. Approximately 20% of affected patients will also develop more severe neuromuscular complications, an important disease subgroup known as DOA(+). Cytochrome c oxidase (COX)-negative fibres and multiple mitochondrial DNA (mtDNA) deletions have been identified in skeletal muscle biopsies from patients manifesting both the pure and syndromal variants, raising the possibility that the accumulation of somatic mtDNA defects contribute to the disease process. In this study, we investigated the mtDNA changes induced by OPA1 mutations in skeletal muscle biopsies from 15 patients with both pure DOA and DOA(+) phenotypes. We observed a 2-to 4-fold increase in mtDNA copy number at the single-fibre level, and patients with DOA(+) features had significantly greater mtDNA proliferation in their COX-negative skeletal muscle fibres compared with patients with isolated optic neuropathy. Low levels of wild-type mtDNA molecules were present in COX-deficient muscle fibres from both pure DOA and DOA(+) patients, implicating haplo-insufficiency as the mechanism responsible for the biochemical defect. Our findings are consistent with the 'maintenance of wild-type' hypothesis, the secondary mtDNA deletions induced by OPA1 mutations triggering a compensatory mitochondrial proliferative response in order to maintain an optimal level of wild-type mtDNA genomes. However, when deletion levels reach a critical level, further mitochondrial proliferation leads to replication of the mutant species at the expense of wild-type mtDNA, resulting in the loss of respiratory chain COX activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available